FdaApplication
NDA 022185
Identifiers
- fda_app_no: NDA022185
Properties
| Property | Value |
|---|---|
| applicant_name | LEO PHARMA AS |
| application_type | NDA |
| approval_date | 2008-05-09 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TACLONEX | BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE | 0.064%;0.005% | SUSPENSION;TOPICAL |
| TACLONEX | BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE | 0.064%;0.005% | SUSPENSION;TOPICAL |
2 products